Concepts (301)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 19 | 2023 | 6773 | 1.470 |
Why?
|
Proton Pump Inhibitors | 6 | 2022 | 526 | 1.350 |
Why?
|
Hepatitis B, Chronic | 8 | 2019 | 393 | 1.300 |
Why?
|
Colonic Polyps | 4 | 2021 | 542 | 0.940 |
Why?
|
Hepatitis B Surface Antigens | 2 | 2016 | 305 | 0.920 |
Why?
|
Adenomatous Polyps | 2 | 2021 | 107 | 0.910 |
Why?
|
Diverticulitis, Colonic | 2 | 2021 | 128 | 0.840 |
Why?
|
Feces | 6 | 2023 | 1401 | 0.810 |
Why?
|
Sulfur Compounds | 1 | 2021 | 31 | 0.800 |
Why?
|
Bacteria | 3 | 2021 | 2114 | 0.720 |
Why?
|
Health Occupations | 1 | 2020 | 224 | 0.670 |
Why?
|
Anti-Bacterial Agents | 9 | 2023 | 7181 | 0.660 |
Why?
|
Adenoma | 7 | 2020 | 2174 | 0.650 |
Why?
|
Diet | 13 | 2023 | 7939 | 0.630 |
Why?
|
Hepatitis B virus | 6 | 2016 | 513 | 0.620 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 253 | 0.600 |
Why?
|
Cultural Diversity | 1 | 2020 | 359 | 0.590 |
Why?
|
Diverticulitis | 4 | 2021 | 171 | 0.580 |
Why?
|
Hepatitis B | 2 | 2013 | 695 | 0.570 |
Why?
|
Inflammatory Bowel Diseases | 5 | 2023 | 2425 | 0.560 |
Why?
|
Sulfur | 3 | 2021 | 166 | 0.560 |
Why?
|
Vaccination | 3 | 2022 | 3278 | 0.520 |
Why?
|
Alanine Transaminase | 3 | 2015 | 592 | 0.510 |
Why?
|
Precancerous Conditions | 1 | 2021 | 975 | 0.480 |
Why?
|
Prospective Studies | 39 | 2023 | 53288 | 0.480 |
Why?
|
Self Report | 9 | 2022 | 3558 | 0.460 |
Why?
|
Irritable Bowel Syndrome | 3 | 2023 | 445 | 0.430 |
Why?
|
Feeding Behavior | 4 | 2021 | 3188 | 0.420 |
Why?
|
Carcinoma, Hepatocellular | 7 | 2021 | 2214 | 0.420 |
Why?
|
Coronavirus Infections | 5 | 2020 | 3133 | 0.420 |
Why?
|
Pneumonia, Viral | 5 | 2020 | 3240 | 0.410 |
Why?
|
Health Personnel | 5 | 2021 | 3218 | 0.410 |
Why?
|
Sulfur-Reducing Bacteria | 2 | 2021 | 16 | 0.410 |
Why?
|
Metagenome | 4 | 2023 | 418 | 0.410 |
Why?
|
Metagenomics | 5 | 2021 | 428 | 0.400 |
Why?
|
Hepatitis C, Chronic | 3 | 2019 | 1031 | 0.400 |
Why?
|
Incidence | 17 | 2022 | 20947 | 0.390 |
Why?
|
Biomedical Research | 2 | 2021 | 3309 | 0.380 |
Why?
|
Liver Cirrhosis | 4 | 2017 | 1863 | 0.370 |
Why?
|
Life Style | 2 | 2021 | 3835 | 0.360 |
Why?
|
Middle Aged | 60 | 2022 | 213383 | 0.350 |
Why?
|
Risk Factors | 32 | 2023 | 72290 | 0.340 |
Why?
|
Gastrointestinal Diseases | 1 | 2017 | 1170 | 0.340 |
Why?
|
Adult | 55 | 2023 | 214055 | 0.330 |
Why?
|
Humans | 103 | 2023 | 744343 | 0.320 |
Why?
|
United States | 29 | 2022 | 69872 | 0.310 |
Why?
|
Sweden | 5 | 2023 | 1345 | 0.300 |
Why?
|
Liver Neoplasms | 6 | 2021 | 4253 | 0.290 |
Why?
|
Pandemics | 10 | 2022 | 8388 | 0.290 |
Why?
|
Dietary Fiber | 2 | 2021 | 760 | 0.280 |
Why?
|
Follow-Up Studies | 19 | 2023 | 39050 | 0.270 |
Why?
|
Cesarean Section | 2 | 2023 | 1365 | 0.270 |
Why?
|
Infectious Disease Transmission, Vertical | 1 | 2013 | 1320 | 0.270 |
Why?
|
Age of Onset | 3 | 2021 | 3271 | 0.260 |
Why?
|
Female | 64 | 2023 | 380194 | 0.260 |
Why?
|
Aged | 42 | 2023 | 163280 | 0.250 |
Why?
|
Hepacivirus | 2 | 2011 | 1379 | 0.250 |
Why?
|
Male | 57 | 2023 | 350118 | 0.240 |
Why?
|
Risk Assessment | 9 | 2021 | 23338 | 0.240 |
Why?
|
Brain Ischemia | 1 | 2017 | 3265 | 0.230 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8428 | 0.230 |
Why?
|
Antiviral Agents | 5 | 2015 | 2987 | 0.220 |
Why?
|
Case-Control Studies | 9 | 2023 | 21746 | 0.220 |
Why?
|
Postprandial Period | 2 | 2021 | 292 | 0.220 |
Why?
|
Propionates | 1 | 2023 | 169 | 0.210 |
Why?
|
Vitamin D-Binding Protein | 1 | 2023 | 129 | 0.210 |
Why?
|
Butyrates | 1 | 2023 | 163 | 0.210 |
Why?
|
Dementia | 1 | 2016 | 2518 | 0.210 |
Why?
|
Multivariate Analysis | 8 | 2021 | 12245 | 0.210 |
Why?
|
Diet Surveys | 3 | 2021 | 1173 | 0.210 |
Why?
|
Ageusia | 1 | 2021 | 20 | 0.200 |
Why?
|
Proportional Hazards Models | 8 | 2021 | 12354 | 0.200 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2013 | 2026 | 0.200 |
Why?
|
Public Health | 3 | 2021 | 2603 | 0.190 |
Why?
|
Health Surveys | 3 | 2021 | 4037 | 0.190 |
Why?
|
Hepatitis C | 1 | 2011 | 1591 | 0.190 |
Why?
|
Cough | 2 | 2021 | 555 | 0.190 |
Why?
|
Data Collection | 2 | 2020 | 3341 | 0.190 |
Why?
|
Adenoma, Villous | 1 | 2020 | 15 | 0.180 |
Why?
|
Clinical Pharmacy Information Systems | 1 | 2020 | 103 | 0.180 |
Why?
|
Hydrogen Sulfide | 1 | 2021 | 137 | 0.180 |
Why?
|
Disease Notification | 1 | 2020 | 97 | 0.180 |
Why?
|
Colonoscopy | 5 | 2021 | 1367 | 0.180 |
Why?
|
Time Factors | 9 | 2021 | 40075 | 0.180 |
Why?
|
Defecation | 1 | 2021 | 188 | 0.170 |
Why?
|
Cohort Studies | 12 | 2022 | 40561 | 0.170 |
Why?
|
Hepatitis B e Antigens | 3 | 2015 | 133 | 0.170 |
Why?
|
Appetite | 1 | 2021 | 243 | 0.170 |
Why?
|
Dyspnea | 3 | 2021 | 1303 | 0.170 |
Why?
|
Masks | 1 | 2021 | 197 | 0.170 |
Why?
|
Tooth Loss | 1 | 2020 | 197 | 0.160 |
Why?
|
Career Mobility | 1 | 2020 | 262 | 0.160 |
Why?
|
Young Adult | 15 | 2023 | 56430 | 0.160 |
Why?
|
Rifamycins | 1 | 2017 | 25 | 0.160 |
Why?
|
Age Factors | 7 | 2021 | 18370 | 0.150 |
Why?
|
Hyperinsulinism | 1 | 2021 | 415 | 0.150 |
Why?
|
Biodiversity | 1 | 2020 | 341 | 0.150 |
Why?
|
Diet, Mediterranean | 2 | 2021 | 700 | 0.150 |
Why?
|
Fruit | 2 | 2021 | 1142 | 0.150 |
Why?
|
Vegetables | 2 | 2021 | 1182 | 0.150 |
Why?
|
Fever | 2 | 2021 | 1616 | 0.140 |
Why?
|
Progestins | 1 | 2019 | 306 | 0.140 |
Why?
|
DNA, Viral | 4 | 2016 | 2225 | 0.140 |
Why?
|
Periodontal Diseases | 1 | 2020 | 449 | 0.140 |
Why?
|
Nurses | 4 | 2021 | 2461 | 0.140 |
Why?
|
Nursing Research | 1 | 2017 | 77 | 0.140 |
Why?
|
Specimen Handling | 1 | 2021 | 694 | 0.140 |
Why?
|
Television | 1 | 2019 | 409 | 0.140 |
Why?
|
Social Justice | 1 | 2020 | 456 | 0.140 |
Why?
|
Microsatellite Instability | 1 | 2019 | 684 | 0.140 |
Why?
|
Siblings | 1 | 2020 | 854 | 0.140 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 379 | 0.130 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2021 | 719 | 0.130 |
Why?
|
Communicable Disease Control | 1 | 2022 | 857 | 0.130 |
Why?
|
Obesity | 5 | 2023 | 12745 | 0.130 |
Why?
|
Peritonitis | 1 | 2017 | 365 | 0.130 |
Why?
|
Weight Gain | 3 | 2023 | 2292 | 0.130 |
Why?
|
Stroke | 1 | 2017 | 9981 | 0.130 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.130 |
Why?
|
Aged, 80 and over | 13 | 2022 | 57776 | 0.120 |
Why?
|
Inflammation | 4 | 2023 | 10638 | 0.120 |
Why?
|
Progesterone | 1 | 2019 | 776 | 0.120 |
Why?
|
Minority Groups | 1 | 2022 | 1223 | 0.120 |
Why?
|
Gastroesophageal Reflux | 1 | 2021 | 782 | 0.120 |
Why?
|
Adolescent | 12 | 2022 | 85781 | 0.120 |
Why?
|
Health Status | 3 | 2021 | 4034 | 0.120 |
Why?
|
Population Surveillance | 2 | 2021 | 2616 | 0.110 |
Why?
|
International Cooperation | 1 | 2020 | 1420 | 0.110 |
Why?
|
Energy Intake | 1 | 2021 | 2148 | 0.110 |
Why?
|
Depression | 2 | 2023 | 7766 | 0.110 |
Why?
|
Histocytochemistry | 1 | 2013 | 719 | 0.110 |
Why?
|
Liver Transplantation | 2 | 2014 | 2119 | 0.110 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1411 | 0.110 |
Why?
|
Socioeconomic Factors | 3 | 2021 | 7785 | 0.110 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 11725 | 0.110 |
Why?
|
Comorbidity | 3 | 2018 | 10388 | 0.110 |
Why?
|
Vitamin D Deficiency | 1 | 2022 | 1343 | 0.110 |
Why?
|
Cognition | 2 | 2022 | 6770 | 0.110 |
Why?
|
Heart-Assist Devices | 1 | 2022 | 1194 | 0.100 |
Why?
|
Estrogen Replacement Therapy | 1 | 2019 | 1203 | 0.100 |
Why?
|
Liver Failure | 1 | 2014 | 241 | 0.100 |
Why?
|
Rectal Neoplasms | 1 | 2021 | 1206 | 0.100 |
Why?
|
Estrogens | 1 | 2019 | 1566 | 0.100 |
Why?
|
Biopsy | 2 | 2020 | 6756 | 0.100 |
Why?
|
Prebiotics | 1 | 2021 | 44 | 0.100 |
Why?
|
Mental Health | 2 | 2022 | 3019 | 0.100 |
Why?
|
Overweight | 1 | 2022 | 2371 | 0.100 |
Why?
|
Prevotella | 2 | 2021 | 79 | 0.100 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3086 | 0.090 |
Why?
|
Models, Biological | 3 | 2021 | 9583 | 0.090 |
Why?
|
Blood Glucose | 2 | 2021 | 6256 | 0.090 |
Why?
|
End Stage Liver Disease | 1 | 2013 | 314 | 0.090 |
Why?
|
Cross-Sectional Studies | 6 | 2023 | 25043 | 0.090 |
Why?
|
Computational Biology | 1 | 2021 | 3521 | 0.090 |
Why?
|
Sex Factors | 6 | 2021 | 10397 | 0.080 |
Why?
|
Colitis, Ulcerative | 1 | 2021 | 1912 | 0.080 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 2009 | 248 | 0.080 |
Why?
|
Bacterial Infections | 1 | 2017 | 1401 | 0.080 |
Why?
|
Predictive Value of Tests | 5 | 2021 | 15076 | 0.080 |
Why?
|
Crohn Disease | 1 | 2021 | 2303 | 0.080 |
Why?
|
Carcinoma | 1 | 2020 | 2375 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2214 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2541 | 0.080 |
Why?
|
Severity of Illness Index | 5 | 2021 | 15540 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2022 | 3597 | 0.080 |
Why?
|
Viremia | 1 | 2011 | 736 | 0.080 |
Why?
|
Histamine H2 Antagonists | 2 | 2020 | 165 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3712 | 0.080 |
Why?
|
Constipation | 2 | 2023 | 546 | 0.080 |
Why?
|
Mendelian Randomization Analysis | 2 | 2023 | 967 | 0.070 |
Why?
|
Probiotics | 1 | 2021 | 351 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2013 | 2373 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2021 | 3864 | 0.070 |
Why?
|
Anxiety | 1 | 2021 | 4297 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8663 | 0.070 |
Why?
|
Genome-Wide Association Study | 2 | 2023 | 12261 | 0.070 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2020 | 954 | 0.070 |
Why?
|
Fungi | 1 | 2019 | 327 | 0.070 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2009 | 486 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3647 | 0.070 |
Why?
|
Interferon-alpha | 1 | 2010 | 895 | 0.070 |
Why?
|
Health | 1 | 2019 | 394 | 0.070 |
Why?
|
Prognosis | 4 | 2021 | 29063 | 0.070 |
Why?
|
Cause of Death | 3 | 2022 | 3584 | 0.070 |
Why?
|
Mutation | 3 | 2019 | 29786 | 0.070 |
Why?
|
Software | 1 | 2020 | 4443 | 0.070 |
Why?
|
Cardiovascular Diseases | 2 | 2022 | 15165 | 0.070 |
Why?
|
DNA Methylation | 1 | 2019 | 4286 | 0.070 |
Why?
|
Viruses | 1 | 2019 | 374 | 0.060 |
Why?
|
Polyethylene Glycols | 1 | 2010 | 1182 | 0.060 |
Why?
|
Prevalence | 4 | 2021 | 15226 | 0.060 |
Why?
|
Species Specificity | 1 | 2019 | 2478 | 0.060 |
Why?
|
Gene Expression | 1 | 2018 | 7799 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3255 | 0.060 |
Why?
|
Barrett Esophagus | 1 | 2008 | 494 | 0.060 |
Why?
|
Vitamins | 2 | 2023 | 1622 | 0.060 |
Why?
|
Disease Susceptibility | 2 | 2021 | 1782 | 0.060 |
Why?
|
Retrospective Studies | 8 | 2022 | 77449 | 0.060 |
Why?
|
Cognition Disorders | 1 | 2017 | 4043 | 0.050 |
Why?
|
Disease Progression | 1 | 2019 | 13284 | 0.050 |
Why?
|
Fatty Acids, Volatile | 1 | 2023 | 102 | 0.050 |
Why?
|
Mesalamine | 1 | 2023 | 136 | 0.050 |
Why?
|
Safety | 2 | 2021 | 1186 | 0.050 |
Why?
|
Phylogeny | 1 | 2019 | 2803 | 0.050 |
Why?
|
Fusobacterium | 1 | 2021 | 54 | 0.050 |
Why?
|
Skin Neoplasms | 1 | 2021 | 5686 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5867 | 0.050 |
Why?
|
Odds Ratio | 3 | 2021 | 9849 | 0.050 |
Why?
|
Satiation | 1 | 2021 | 80 | 0.050 |
Why?
|
Bifidobacterium | 1 | 2021 | 100 | 0.050 |
Why?
|
California | 3 | 2010 | 1402 | 0.050 |
Why?
|
Blastocystis | 1 | 2021 | 19 | 0.050 |
Why?
|
Food Microbiology | 1 | 2021 | 78 | 0.050 |
Why?
|
Sigmoidoscopy | 1 | 2021 | 156 | 0.050 |
Why?
|
Fast Foods | 1 | 2022 | 197 | 0.050 |
Why?
|
Body Weight | 2 | 2023 | 4669 | 0.050 |
Why?
|
Taste Disorders | 1 | 2020 | 41 | 0.050 |
Why?
|
Hunger | 1 | 2021 | 198 | 0.040 |
Why?
|
England | 1 | 2020 | 522 | 0.040 |
Why?
|
Caloric Restriction | 1 | 2021 | 302 | 0.040 |
Why?
|
Vitamin D | 2 | 2023 | 3223 | 0.040 |
Why?
|
Mass Screening | 3 | 2022 | 5255 | 0.040 |
Why?
|
Metabolic Networks and Pathways | 1 | 2023 | 783 | 0.040 |
Why?
|
Israel | 1 | 2021 | 796 | 0.040 |
Why?
|
Heart Failure | 1 | 2022 | 10900 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2014 | 3158 | 0.040 |
Why?
|
Computer Systems | 1 | 2020 | 483 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1730 | 0.040 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 407 | 0.040 |
Why?
|
Body Mass Index | 3 | 2022 | 12720 | 0.040 |
Why?
|
Epidemiologic Studies | 1 | 2021 | 676 | 0.040 |
Why?
|
Olfaction Disorders | 1 | 2020 | 222 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13695 | 0.040 |
Why?
|
Pregnancy | 2 | 2023 | 29144 | 0.040 |
Why?
|
Neuropsychological Tests | 2 | 2022 | 6993 | 0.040 |
Why?
|
Waist-Hip Ratio | 1 | 2018 | 517 | 0.040 |
Why?
|
Hyperplasia | 1 | 2020 | 1185 | 0.040 |
Why?
|
Exercise | 2 | 2023 | 5615 | 0.040 |
Why?
|
Diarrhea | 1 | 2023 | 1348 | 0.030 |
Why?
|
Causality | 1 | 2023 | 1275 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2021 | 1184 | 0.030 |
Why?
|
Europe | 1 | 2023 | 3339 | 0.030 |
Why?
|
Delivery, Obstetric | 1 | 2023 | 906 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2023 | 63114 | 0.030 |
Why?
|
Disease Transmission, Infectious | 1 | 2021 | 547 | 0.030 |
Why?
|
Ascites | 1 | 2017 | 344 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2022 | 1130 | 0.030 |
Why?
|
Oral Health | 1 | 2020 | 472 | 0.030 |
Why?
|
Colectomy | 1 | 2020 | 683 | 0.030 |
Why?
|
Obesity, Abdominal | 1 | 2018 | 361 | 0.030 |
Why?
|
Fasting | 1 | 2021 | 1593 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2020 | 824 | 0.030 |
Why?
|
Chest Pain | 1 | 2021 | 1114 | 0.030 |
Why?
|
Waist Circumference | 1 | 2018 | 917 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2021 | 14722 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2012 | 0.030 |
Why?
|
Fatigue | 1 | 2020 | 1531 | 0.030 |
Why?
|
Viral Load | 2 | 2012 | 3299 | 0.030 |
Why?
|
Propensity Score | 1 | 2019 | 1781 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1889 | 0.030 |
Why?
|
Nutrition Surveys | 1 | 2019 | 1660 | 0.030 |
Why?
|
Genotype | 3 | 2012 | 12951 | 0.030 |
Why?
|
Hemodynamics | 1 | 2022 | 4199 | 0.030 |
Why?
|
Neoplasms | 1 | 2020 | 21683 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2017 | 1530 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2019 | 1889 | 0.020 |
Why?
|
Risk | 1 | 2023 | 9687 | 0.020 |
Why?
|
Texas | 1 | 2010 | 392 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2021 | 3778 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6459 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2017 | 4933 | 0.020 |
Why?
|
Child, Preschool | 2 | 2022 | 41006 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2017 | 1901 | 0.020 |
Why?
|
Aspirin | 1 | 2021 | 3282 | 0.020 |
Why?
|
SEER Program | 1 | 2014 | 1508 | 0.020 |
Why?
|
Glucose | 1 | 2021 | 4397 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2864 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6196 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2020 | 3589 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2020 | 3586 | 0.020 |
Why?
|
Memory | 1 | 2017 | 2174 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10943 | 0.020 |
Why?
|
Linear Models | 1 | 2017 | 5952 | 0.020 |
Why?
|
Attention | 1 | 2017 | 2400 | 0.020 |
Why?
|
Chronic Disease | 1 | 2021 | 9146 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12788 | 0.020 |
Why?
|
Phenotype | 1 | 2023 | 16365 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2008 | 345 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5137 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13989 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8089 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2023 | 15519 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2014 | 2585 | 0.010 |
Why?
|
Child | 2 | 2021 | 77709 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9438 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6622 | 0.010 |
Why?
|
Survival Analysis | 1 | 2013 | 10252 | 0.010 |
Why?
|
Infant | 1 | 2021 | 35136 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11031 | 0.010 |
Why?
|
Animals | 1 | 2019 | 168757 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 13881 | 0.010 |
Why?
|
Concepts
(301)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(101)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_